This case-based activity is designed to help pathologists and laboratory professionals increase their knowledge, skills, and competence in applying practice-changing updates regarding HER2-low and HER2-ultralow advanced breast cancer. Through three case-based microlearning activities learners will answer questions designed to help them carefully consider the nuances of HER2-low and HER2-ultralow breast cancer diagnosis. This is the first of the three activities and focuses on HER2 classification, tracking and reporting considerations and HER2 IHC testing and interpretation in HER2-low breast cancers.
Course Topics Include:
- HER2 immunohistochemistry
- Impact of pre-analytical variables on HER2 immunohistochemistry
- CAP/ASCO 2023 HER2 immunohistochemistry guidelines
Target Audience
This activity has been designed to meet the educational needs of pathologists and laboratory professionals.
Learning Objectives
Upon completion of this activity, you will be able to:
- Interpret HER2 immunohistochemistry results using established scoring criteria to guide clinical decision making
- Evaluate the impact of pre-analytical variables on HER2 IHC accuracy
- Utilize CAP/ASCO 2023 HER2 immunohistochemistry guidelines to enhance the accuracy of HER2 classification, ensuring optimal biomarker interpretation for treatment decision-making
Faculty
Dr. Swikrity U Baskota, MBBS,MD
Assistant Professor
Department of Pathology and Laboratory Medicine
University of California Davis Health System
Faculty Disclosures
Dr. Baskota has no relevant financial relationships to disclose.
Accreditation Statement
The American Society for Clinical Pathology (ASCP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.
Credit Designation Statement
The ASCP designates this activity for a maximum of .25 AMA PRA Category 1 Credit(s)â„¢. Physicians should claim only credit commensurate with the extent of their participation in the activity.
ASCP designates this activity for a maximum of .25 CMLE credit. This activity meets CMP and state re-licensure requirements for laboratory personnel.
For questions regarding CME credit, please contact ASCP Customer Service at 1-800-267-2727, option 2, in the US & Canada or internationally at access code + 3-1-312-541-4890. Monday-Friday, 8am-5pm CT.
Method of Participation
To complete the activity and receive credit, the participant complete the program. CME certificates will be provided online.
Commercial Support
This activity is supported by independent educational grants from AstraZeneca Pharmaceuticals and Daiichi Sankyo, Inc.